Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 2.43%.

  • Lucid Diagnostics' Return on Capital Employed rose 7700.0% to 2.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.43%, marking a year-over-year increase of 7700.0%. This contributed to the annual value of 8.42% for FY2024, which is 871100.0% up from last year.
  • Per Lucid Diagnostics' latest filing, its Return on Capital Employed stood at 2.43% for Q3 2025, which was up 7700.0% from 7.6% recorded in Q2 2025.
  • Lucid Diagnostics' Return on Capital Employed's 5-year high stood at 9.92% during Q1 2025, with a 5-year trough of 55.41% in Q4 2023.
  • In the last 4 years, Lucid Diagnostics' Return on Capital Employed had a median value of 3.27% in 2023 and averaged 7.98%.
  • In the last 5 years, Lucid Diagnostics' Return on Capital Employed plummeted by -533300bps in 2023 and then soared by 407100bps in 2024.
  • Over the past 4 years, Lucid Diagnostics' Return on Capital Employed (Quarter) stood at 2.08% in 2022, then tumbled by -2561bps to 55.41% in 2023, then skyrocketed by 73bps to 14.7% in 2024, then surged by 83bps to 2.43% in 2025.
  • Its Return on Capital Employed was 2.43% in Q3 2025, compared to 7.6% in Q2 2025 and 9.92% in Q1 2025.